FY26 EBITDA guidance of ₹1,800-1,850 crore
Management reiterated EBITDA guidance of ₹1,800-1,850 crore for FY26, implying ~12% margin for the year.
UFLEX / guidance tracker
Keep management guidance in view.
Uflex · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
margins
FY26 aseptic packaging volume guidance of ~8.5 billion packs
Aseptic packaging volumes expected to reach ~8.5 billion packs for FY26, with Q4 and Q1 being peak seasons.
Three major projects commissioning within 90 days
Egypt aseptic expansion, India recycling plant, and Mexico woven bags plant expected to commission within 90 days, with full capacity utilization targeting incremental revenue of ₹2,000-2,500 crore at ~20% margins.
FY27 EBITDA margin improvement expected
Management expects EBITDA margins to improve further in FY27 driven by better product mix, price recovery, and new project contributions.